Intervet

Equine Vaccine

EQUINE RHINOPNEUMONITIS VACCINE

KILLED VIRUS

An inactivated, purified, concentrated, adjuvanted, tissue culture origin Equine Herpesvirus EHV-1 vaccine.

INDICATIONS: For vaccination of healthy horses 6 months of age or older, as an aid in the prevention of abortion and respiratory disease associated with Equine Herpesvirus 1 infection.

DOSE: For pregnant mares administer a 2 mL dose intramuscularly in the 5th, 7th and 9th months of pregnancy. Three doses are essential for primary immunization. Maiden and barren mares housed or pastured with pregnant mares should be vaccinated on the same schedule. For primary immunization against respiratory disease administer three 2 mL doses intramuscularly at 4 to 6 week intervals. A 2 mL booster dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent.

CAUTION: Store at 35° to 45°F (2° to 7°C). Shake well before using. Use entire contents when first opened (10 doses). Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep in the muscle only. Anaphylactoid reactions may occur.

CAUTION: Needle is sharp and may cause injury to self or animals if not handled properly or disposed of properly.

ANTIDOTE: Epinephrine.

PRESERVATIVES: Neomycin, gentamicin and thimerosal.

*Adjuvant-Intervet's Proprietary Technology

FOR USE IN ANIMALS ONLY

Intervet Inc., Millsboro, DE 19966

1-800-441-8272

www.intervetusa.com

U.S. Veterinary License No. 286

NAC No.: 11061313